Atlassian Corp

Atlassian insider sales reveal a disciplined 10b5‑1 plan and routine profit‑taking, but fundamentals—cloud revenue, AI growth, and earnings—remain strong.

CEO Mike Cannon‑Brookes sells 8,565 Atlassian shares under a 10b‑5 plan, revealing a routine liquidity move amid a 52‑week low but strong AI‑driven growth outlook.

Insider sales spike at Atlassian: CEO Michael Cannon‑Brookes sells 5,200 shares—what this means for investors and stock value in a volatile market.

Insider selling sprees at Atlassian: Farquhar Scott’s 3,500‑share dump amid a steep 70% decline, yet AI‑roadmap and disciplined 10b‑5‑1 plan suggest it’s portfolio management, not panic.

Atlassian insider moves reveal a quiet upside: a CEO grant shows long‑term confidence, while founder sales are routine, yet AI growth keeps the stock attractive for investors.

CEO Michael Cannon‑Brookes sells 13,842 Atlassian shares in a routine 10b‑5‑1 move—no crisis, just liquidity. Learn how this impacts investors and the stock’s outlook.

Atlassian CEO’s 10b5‑1 insider sale: 13,521 shares sold at €133.69 on Jan 27, 2026—steady, rule‑based moves with minimal market impact but key signals for investors.

Atlassian CEO Michael Cannon‑Brookes sells 6,088 shares via Rule 10b5‑1: what it signals for stock, investor sentiment, and next‑quarter earnings.

Atlassian’s CEO sells over 5 million shares in a single month—why the insider outflow matters for shareholders and what it signals about the company’s valuation and growth prospects.

CEO Michael Cannon‑Brookes sells 10k Atlassian shares via a Rule‑10b5‑1 plan—little immediate impact, but a sign to watch for long‑term growth amid AI expansion.